If most public chains are still 'grabbing topics', Injective has already begun to speak with products and structured layouts. With the native EVM about to launch, developers will be able to build high-performance, cross-chain DeFi applications in a familiar Ethereum-compatible environment. Currently, over 40 dApps and infrastructure projects are preparing to join, injecting liquidity, tools, and user entry points into the Injective ecosystem, accelerating its development into a professional-grade on-chain financial foundation.

What is even more intriguing is the signals from the funding side. NYSE-listed company Pineapple Financial announced it would invest $100 million in INJ through a systematic investment in the open market, and an Injective-related ETF is also about to open to U.S. market investors. The simultaneous arrival of institutional funds and compliance tools increases INJ's buying interest and depth, while also indicating that traditional capital markets are beginning to acknowledge the growth potential of this emerging public chain.

In the RWA direction, Injective has turned the narrative into reality: moving assets such as stocks, gold, foreign exchange, and digital forms of government bonds onto the chain, and has already supported direct trading of assets like Nvidia on-chain. Users can access real asset targets within the DeFi system while enjoying advantages such as transparency of on-chain assets, rapid settlement, and strong composability.

While many projects in the industry are still pursuing short-term 'hype indicators', Injective's path leans more towards 'infrastructure engineering': slowly building protocols, liquidity, and asset bridges. What it is genuinely trying to capture is the underlying discourse power of the next-generation financial system, rather than a short-term story of ups and downs.